Related Experiment Video
Updated: Jul 19, 2026

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides
Published on: September 16, 2020
Targeting antioxidants to mitochondria by conjugation to lipophilic cations
Michael P Murphy1, Robin A J Smith
1MRC Dunn Human Nutrition Unit, Wellcome Trust/MRC Building, Cambridge CB2 2XY, United Kingdom. mpm@mrc-dunn.cam.ac.uk
Abstract:
Mitochondrial oxidative damage contributes to a range of degenerative diseases. Consequently, the selective inhibition of mitochondrial oxidative damage is a promising therapeutic strategy. One way to do this is to invent antioxidants that are selectively accumulated into mitochondria within patients. Such mitochondria-targeted antioxidants have been developed by conjugating the lipophilic triphenylphosphonium cation to an antioxidant moiety, such as ubiquinol or alpha-tocopherol. These compounds pass easily through all biological membranes, including the blood-brain barrier, and into muscle cells and thus reach those tissues most affected by mitochondrial oxidative damage. Furthermore, because of their positive charge they are accumulated several-hundredfold within mitochondria driven by the membrane potential, enhancing the protection of mitochondria from oxidative damage. These compounds protect mitochondria from damage following oral delivery and may therefore form the basis for mitochondria-protective therapies. Here we review the background and work to date on this class of mitochondria-targeted antioxidants.
Insights
Mitochondria-targeted antioxidants, developed by linking a positive charge to antioxidants, accumulate within mitochondria. These compounds show promise for treating degenerative diseases by protecting mitochondria from oxidative damage after oral delivery.
Area of Science:
- Biochemistry
- Pharmacology
- Cell Biology
Background:
- Mitochondrial oxidative damage is implicated in various degenerative diseases.
- Targeting antioxidants to mitochondria is a potential therapeutic approach.
- Mitochondria-targeted antioxidants can be developed using lipophilic cations.
Purpose of the Study:
- To review the development and efficacy of mitochondria-targeted antioxidants.
- To explore their potential in treating diseases associated with mitochondrial oxidative damage.
Main Methods:
- Conjugation of lipophilic triphenylphosphonium cation to antioxidant moieties (ubiquinol, alpha-tocopherol).
- Assessment of compound ability to cross biological membranes, including the blood-brain barrier.
- Evaluation of mitochondrial accumulation driven by membrane potential.
- Testing efficacy following oral delivery in protecting mitochondria from oxidative damage.
Main Results:
- Mitochondria-targeted antioxidants readily cross biological membranes and accumulate within mitochondria.
- These compounds demonstrate protective effects against mitochondrial oxidative damage.
- Oral administration leads to effective mitochondria protection.
Conclusions:
- Mitochondria-targeted antioxidants represent a promising therapeutic strategy for degenerative diseases.
- Their selective accumulation and protective effects offer a novel approach to mitochondria-based therapies.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Electron Transport Chain: Complex III and IV
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Mitochondrial Precursor Proteins
Most of the mitochondrial precursors...
